Post-Transplantation B Cell Activating Factor and B Cell Recovery before Onset of Chronic Graft-versus-Host Disease

Caron A. Jacobson, Lixian Sun, Haesook T. Kim, Sean M. McDonough, Carol G. Reynolds, Michael Schowalter, John Koreth, Corey S. Cutler, Vincent T. Ho, Edwin P. Alyea, Philippe Armand, Bruce R. Blazar, Robert J. Soiffer, Joseph H. Antin, Jerome Ritz, Stefanie Sarantopoulos

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


Excessive levels of B cell activating factor (BAFF) are found in patients with active chronic graft-versus-host disease (cGVHD). In mice, BAFF has been shown to be essential for B cell recovery after myeloablation. To assess how BAFF levels relate to transplantation factors and subsequent development of cGVHD, we prospectively monitored 412 patients in the first year after allogeneic peripheral blood or bone marrow hematopoietic stem cell transplantation (HSCT) and censored data at time of cGVHD onset. In patients who did not develop cGVHD, we affirmed a temporal pattern of gradually decreasing BAFF levels as B cell numbers increase after myeloablative conditioning. In contrast, after reduced-intensity conditioning, BAFF levels remained high throughout the first post-HSCT year, suggesting that the degree of myeloablation resulted in delayed B cell recovery associated with persistence of higher BAFF levels. Given that high BAFF/B cell ratios have been associated with active cGVHD, we examined differences in early BAFF/B cell ratios and found significantly different BAFF/B cell ratios at 3 months post-HSCT only after myeloablative conditioning in patients who subsequently developed cGVHD. In addition to HSCT conditioning type, the use of sirolimus was significantly associated with higher BAFF levels after HSCT, and this also was potentially related to lower B cell numbers. Taken together, our results are important for interpreting BAFF measurements in cGVHD biomarker studies.

Original languageEnglish (US)
Pages (from-to)668-675
Number of pages8
JournalBiology of Blood and Marrow Transplantation
Issue number5
StatePublished - May 2014

Bibliographical note

Funding Information:
Financial disclosure: This study was supported by National Institues of Health grants P01 CA142106 and K08 HL107756 , the Dunkin' Donuts Rising Stars Program , the Triad Golfers Against Cancer, the Jock and Bunny Adams Research and Education Endowment , and the Ted and Eileen Pasquarello Research Fund .


  • B cell
  • B cell activating factor
  • Chronic graft-versus-host disease


Dive into the research topics of 'Post-Transplantation B Cell Activating Factor and B Cell Recovery before Onset of Chronic Graft-versus-Host Disease'. Together they form a unique fingerprint.

Cite this